Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Alamar Biosciences EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.19 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.22 | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.74 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.69 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.62 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.68 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?